Literature DB >> 8891362

Cerebral hypoxia after hyperventilation causes "re-build-up" phenomenon and TIA in childhood moyamoya disease. A near-infrared spectroscopy study.

S Kuroda1, K Houkin, Y Hoshi, M Tamura, K Kazumata, H Abe.   

Abstract

Near-infrared spectroscopy was used to monitor the sequential changes in the cerebral oxygenation state during and after hyperventilation in two children with moyamoya disease. Hyperventilation induced the build-up phenomenon and a decrease in the concentration of oxy-hemoglobin ([oxy-Hb]) and total hemoglobin ([t-Hb]). The termination of hyperventilation was followed by partial recovery of [oxy-Hb] and [t-Hb]. Subsequently, however, [oxy-Hb] and [t-Hb] decreased again and cytochrome oxidase was reduced. These impairments of the cerebral hemodynamics and oxygen metabolism were closely associated with the re-build-up phenomenon on EEG and with transient ischemic attacks (TIA). The present study implies that cerebral hypoxia after hyperventilation is closely related to the re-build-up phenomenon and ischemic attacks in children with moyamoya disease.

Entities:  

Mesh:

Year:  1996        PMID: 8891362     DOI: 10.1007/bf00261621

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  29 in total

1.  Worldwide distribution of moyamoya disease.

Authors:  Y Goto; Y Yonekawa
Journal:  Neurol Med Chir (Tokyo)       Date:  1992-11       Impact factor: 1.742

2.  Measurement of regional cerebrovascular haemoglobin oxygen saturation in cats using optical spectroscopy.

Authors:  P W McCormick; M Stewart; P Ray; G Lewis; M Dujovny; J I Ausman
Journal:  Neurol Res       Date:  1991-03       Impact factor: 2.448

3.  Regional cerebral hemodynamics during re-build-up phenomenon in childhood moyamoya disease. An analysis using 99mTc-HMPAO SPECT.

Authors:  K Kazumata; S Kuroda; K Houkin; H Abe; K Mitumori
Journal:  Childs Nerv Syst       Date:  1996-03       Impact factor: 1.475

4.  Near infrared quadruple wavelength spectrophotometry of the rat head.

Authors:  O Hazeki; M Tamura
Journal:  Adv Exp Med Biol       Date:  1989       Impact factor: 2.622

Review 5.  Moyamoya disease.

Authors:  Y Maki; T Enomoto
Journal:  Childs Nerv Syst       Date:  1988-08       Impact factor: 1.475

6.  Regional cerebrovascular oxygen saturation measured by optical spectroscopy in humans.

Authors:  P W McCormick; M Stewart; M G Goetting; G Balakrishnan
Journal:  Stroke       Date:  1991-05       Impact factor: 7.914

7.  EEG suppression and anoxic depolarization: influences on cerebral oxygenation during ischemia.

Authors:  C N Raffin; M Harrison; T J Sick; M Rosenthal
Journal:  J Cereb Blood Flow Metab       Date:  1991-05       Impact factor: 6.200

8.  Oxygen dependence of redox state of copper in cytochrome oxidase in vitro.

Authors:  Y Hoshi; O Hazeki; M Tamura
Journal:  J Appl Physiol (1985)       Date:  1993-04

9.  Intracerebral penetration of infrared light. Technical note.

Authors:  P W McCormick; M Stewart; G Lewis; M Dujovny; J I Ausman
Journal:  J Neurosurg       Date:  1992-02       Impact factor: 5.115

10.  Cerebral hemodynamic change in the child and the adult with moyamoya disease.

Authors:  Y Kuwabara; Y Ichiya; M Otsuka; T Tahara; R Gunasekera; K Hasuo; K Masuda; T Matsushima; M Fukui
Journal:  Stroke       Date:  1990-02       Impact factor: 7.914

View more
  2 in total

1.  Source localization of the re-build up phenomenon in pediatric moyamoya disease-a dipole distribution analysis using MEG and SPECT.

Authors:  Fan Qiao; Satoshi Kuroda; Kyousuke Kamada; Kiyohiro Houkin; Yoshinobu Iwasaki
Journal:  Childs Nerv Syst       Date:  2003-10-11       Impact factor: 1.475

2.  Intraoperative infrared brain surface blood flow monitoring during superficial temporal artery-middle cerebral artery anastomosis in patients with childhood moyamoya disease.

Authors:  Atsuhiro Nakagawa; Miki Fujimura; Tatsuhiko Arafune; Ichiro Sakuma; Teiji Tominaga
Journal:  Childs Nerv Syst       Date:  2008-07-12       Impact factor: 1.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.